Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 24SevenOffice 247 May 14, 2021 32.50 +1.56   
 24Storage 24STOR May 14, 2021 42.90 -0.23   
 2cureX 2CUREX May 14, 2021 23.75 +2.81   
 AAC Clyde Space AAC May 14, 2021 2.31 -2.32   
 AAK AAK May 14, 2021 190.35 +1.52   
 ABB ABB May 14, 2021 284.20 +3.16   
 Abelco Investment Group ABIG May 14, 2021 0.11 0.00   
 Abera Bioscience ABERA May 14, 2021 11.90 0.00   
 Abliva ABLI May 14, 2021 0.68 -2.59   
 Absolent Group ABSO May 14, 2021 397.00 -1.98   
 Absolicon ABSL May 14, 2021 132.50 0.00   
 AcadeMedia ACAD May 14, 2021 80.20 +0.88   
 Acarix ACARIX May 14, 2021 1.46 -6.41   
 Acconeer ACCON May 14, 2021 42.25 +1.08   
 Acosense ACOS May 14, 2021 1.54 -0.96   
 AcouSort ACOU May 14, 2021 24.90 +5.29   
 ACQ Bure ACQSPAC 0.00 0.00   
 Acrinova A ACRIA May 14, 2021 11.28 0.00   
 Acrinova B ACRIB May 14, 2021 12.15 0.00   
 ACROUD ACROUD May 14, 2021 3.60 +4.05   
 Actic Group ATIC May 14, 2021 18.15 +1.11   
 Active Biotech ACTI May 14, 2021 1.45 -0.27   
 AcuCort ACUC May 14, 2021 4.93 +6.94   
 Adapteo ADAPT May 14, 2021 108.00 +4.45   
 AdderaCare ADDERA May 14, 2021 6.62 -7.54   
 AddLife B ALIFB May 14, 2021 206.00 -1.62   
 Addnode Group B ANODB May 14, 2021 299.50 -0.17   
 Addtech B ADDTB May 14, 2021 143.00 -2.05   
 ADDvise Group A ADDVA May 14, 2021 3.30 +1.85   
 ADDvise Group B ADDVB May 14, 2021 3.13 +6.11   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK